0.05Open0.05Pre Close0 Volume1 Open Interest12.50Strike Price0.00Turnover452.95%IV783.80%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0968Delta0.1043Gamma28.40Leverage Ratio-0.0058Theta0.0001Rho2.75Eff Leverage0.0006Vega
Rani Therapeutics Stock Discussion
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
No comment yet